Car Sales Still Spe...
Health Care: Health Services
Exactech Inc. (EXAC: NASDAQ)
$15.12 -0.13 | -0.85%
06/04/12 - 12:06 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 21.80 | 25.70 | 17.70 |
| P/E High - Last 5 Yrs | 36.50 | 49.70 | 67.70 |
| P/E Low - Last 5 Yrs | 14.90 | 19.70 | 12.50 |
| Beta | 0.68 | 0.83 | 0.98 |
| Price to Sales (TTM) | 0.95 | 2.60 | 1.42 |
| Price to Book (MRQ) | 1.25 | 2.62 | 2.41 |
| Price to Tangible Book (MRQ) | 1.52 | 10.66 | 5.08 |
| Price to Cash Flow (TTM) | 7.80 | 15.40 | 9.80 |
| Price to Free Cash Flow (TTM) | -54.00 | 35.90 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.70 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.70 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 12.44 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 20.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 9.90 | 12.60 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 7.80 | 20.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 13.15 | 11.49 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | 10.60 | 10.30 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | 10.60 | 10.30 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | -2.56 | 8.89 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 29.70 | 4.24 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 1.90 | 1.90 | 1.10 |
| Current Ratio (MRQ) | 4.30 | 2.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.30 | 0.30 | 0.82 |
| Total Debt to Equity (MRQ) | 0.31 | 0.35 | 0.96 |
| Interest Coverage (TTM) | 11.50 | 14.90 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 69.40 | 70.50 | 46.90 |
| Gross Margin - 5 Yr Avg | 66.20 | 69.30 | 47.70 |
| EBITD Margin (TTM) | 15.00 | 28.60 | 18.90 |
| EBITD - 5 Yr Avg | 17.54 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 6.60 | 18.50 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 9.00 | 15.70 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.04 | 0.14 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 5.50 | 11.10 | 7.00 |
| Return on Assets (TTM) | 3.80 | 8.40 | 3.10 |
| Return on Assets - 5 Yr Avg | 5.20 | 7.30 | 2.50 |
| Return on Investment (TTM) | 4.40 | 10.90 | 7.90 |
| Return on Investment - 5 Yr Avg | 6.20 | 9.60 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 366,997.00 | 414,937.00 | 449,376.00 |
| Net Income/Employee (TTM) | 15,923.00 | 56,730.00 | 39,003.00 |
| Receivable Turnover (TTM) | 4.30 | 5.10 | 7.60 |
| Inventory Turnover (TTM) | 1.00 | 2.10 | 8.30 |
| Asset Turnover (TTM) | 0.90 | 0.70 | 0.40 |
Portfolios with EXAC
- Portfolio NameUser Type
- UserDustin
- UserRick's 401K
- Userljc
- UserPART 3 JPMorgan 27th Annual...
- UserCP2201 Portfolio 1
- UserJuly, Aug, Sept 08 Conferen...
- UserHorizon II
- Usercat3rn
- UserGowest 2
- Usersmall but interesting
Latest EXAC Headlines from TheStreet
- Exactech's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 01:05 pm
- Exactech's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.29.12 | 04:02 pm
- Exactech Inc. Stock Upgraded (EXAC) 02.23.12 | 04:02 am
- Exactech's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.02.11 | 01:11 pm
- Exactech Inc. Stock Downgraded (EXAC) 08.23.11 | 07:08 am
- Exactech Stock Soars (EXAC) 08.09.11 | 04:08 pm
- Exactech's CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.03.11 | 03:08 pm
- Exactech Inc. Stock Upgraded (EXAC) 06.01.11 | 07:06 am
- Exactech CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.04.11 | 03:05 pm
- Exactech CEO Discusses Q4 2010 - Earnings Call Transcript 02.28.11 | 11:02 am
Press Releases for EXAC
- Exactech Q1 Revenue Up 10% To $58.6 Million, Net Income $3.3 Million, Diluted EPS $0.25 - Business Wire 05.01.12 | 04:05 pm
- Exactech Schedules First Quarter 2012 Earnings Release And Conference Call - Business Wire 04.17.12 | 02:04 pm
- Exactech Announces Expiration Of Deferred Prosecution Agreement - Business Wire 03.15.12 | 12:03 pm
- Exactech 2011 Revenue Up 8% To $205M; Net Income $8.8M, EPS $0.67; Q4 Net Income $1.8M, EPS $0.14 - Business Wire 02.28.12 | 04:02 pm
- Exactech Announces $100 Million Long Term Syndicated Credit Facility - Business Wire 02.27.12 | 04:02 pm
- Exactech Announces Product Lineup For Exhibit At American Academy Of Orthopaedic Surgeons Meeting; Management To Present At Investor Conference - Business Wire 02.06.12 | 10:02 am
- Exactech Announces Preliminary 2011 Sales Of $205.4 Million And 4th Quarter 2011 Sales Of $53.1 Million - Business Wire 01.31.12 | 09:01 am
- Exactech To Present To Investors At The 2012 Noble Financial Equity Conference On January 17 - Business Wire 01.09.12 | 10:01 am
- Exactech Initiates Multi-Center Clinical Trial For New Cartilage Regeneration Technology - Business Wire 12.19.11 | 09:12 am
- Exactech Continues To Expand Spine Portfolio With Comprehensive Solution To Posterior Cervical Fusion - Business Wire 12.08.11 | 03:12 pm
Partner Headlines for EXAC
- Benchmark Initiates Coverage on Exactech with Buy Rating, $21 PT - Benzinga 05.18.12 | 09:05 am
- Exactech Underperforms in 4Q - Analyst Blog - Zacks 03.02.12 | 09:03 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 01.03.12 | 09:01 am
- Hanger's 3Q Mixed, View Lowered - Analyst Blog - Zacks 10.28.11 | 05:10 pm
- Hanger Retained at Neutral - Analyst Blog - Zacks 08.18.11 | 07:08 pm
- Exactech Expands Spine Biz - Analyst Blog - Zacks 06.01.11 | 07:06 pm
- Hanger Remains Outperform - Analyst Blog - Zacks 05.16.11 | 08:05 pm
- Hanger's EPS Meets, Profit Soars - Analyst Blog - Zacks 04.28.11 | 10:04 am
- Exactech 4Q EPS Meets, Rev Beats - Analyst Blog - Zacks 03.02.11 | 10:03 am
- Hanger Tops, Charges Hit Profit - Analyst Blog - Zacks 02.10.11 | 06:02 pm
